MICHAEL CASAL: Open Payments
NPI 1568551638 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 11 payments from 5 companies in 2025. Trend: 2023 $355 · 2024 $167 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Sage Therapeutics, LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $35 |
| Organon LLC | 1 | $23 |
Products named: Veozah, CAPLYTA, ZURZUVAE, Wegovy, NEXPLANON.
Industry payments across TN — which companies pay providers there.
